ABSTRACT
Microbial fuel cells are the electrochemical exchangers that convert the microbial reduced power, generated via the metabolism of organic substrate, to electrical energy. The aim of this study is to find out the rate of produced electricity and also treatment rate of simulated wastewater of food industries using dual chamber microbial fuel cell [MFC] without mediator and catalyst. MFC used in this study was consisted of two compartments including anaerobic anode chamber containing simulated food industries wastewater as synthetic substrate and aerobic cathode chamber containing phosphate buffer, respectively. These two chambers were separated by proton exchange membrane made of Nafion. Produced voltage and current intensity were measured using a digital ohm meter and the amount of electricity was calculated by Ohm's law. Effluent from the anode compartment was tested for COD, BOD5, NH3, P, TSS, VSS, SO42- and alkalinity in accordance with the Standard Methods. In this study, maximum current intensity and power production at anode surface in the OLR of 0.79 Kg/m3.d were measured as 1.71 mA and 140 mW/m2, respectively. The maximum voltage of 0.422 V was obtained in the OLR of 0.36 Kg/m3.d. The greatest columbic efficiency of the system was 15% in the OLR of 0.18 Kg/m3.d. Maximum removal efficiency of COD, BOD5, NH3, P, TSS, VSS, SO42- and alkalinity, were obtained 78, 72, 66, 7, 56, 49, 26 and 40%, respectively. The findings showed that the MFC can be used as a new technology to produce electricity from renewable organic materials and for the treatment of different municipal and industrial wastewaters such as food industries
Subject(s)
Bioelectric Energy Sources , Electrochemical Techniques , Food Industry , ElectrodesABSTRACT
Matricaria chamomilla [MC] contains flavonoids, which exert benzodiazepine-like activity and so it may be helpful in morphine withdrawal syndrome [MWS] treatment. To determine the effects of MC extract on morphine withdrawal syndrome signs in adult male mice. This was an experimental study carried out in two steps at the department of physiology, Qazvin School of medicine [Iran], in 2005. Step 1: 3 adult male mice [n=6] were originally divided into 2 groups marked as saline [control] and morphine [case] groups. The morphine group were injected by increasing doses of morphine [10, 20, 40 mg/kg, s.c], 3 times daily, for a total duration of 4 days and were further divided into 4 subgroups as morphine group and 3 MC extract groups receiving one dose of MC extract [10, 20 or 30 mg/kg I.P] at day 4, 30 min before naloxone injection. At the end of training day [4[th] days] all groups were injected by naloxone [5mg/kg I.P] and MWS was studied for 30 minutes. Step 2: another 30 adult male mice [n=6] were injected by saline, morphine and MC extracts as above except for morphine and naloxane which were injected as one single dose [50 mg/kg]. Naloxone was injected 3hr after the last injection of morphine and the frequencies of withdrawal behaviors [jumping, climbing] were assessed later. The results of the present study showed that the acute and chronic administration of MC at doses used in our experiment significantly abolished the morphine withdrawal syndrome signs [jumping, climbing, writhing, weight loss] compared with morphine group. Our data suggest that the MC can attenuate the expression of withdrawal behaviors in male mice